gk activator
Small moleculeexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00266240)
Timeline
Indications
Studied for
Mechanism of action
- Hexokinase type IVACTIVATOR
GCK activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gk activator
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00437606 | Phase 1 | Mar 1, 2007 | Roche |
| NCT00388986 | Phase 1 | Oct 1, 2006 | Roche |
| NCT00377442 | Phase 1 | Aug 1, 2006 | Roche |
| NCT00366379 | Phase 2 | Jul 1, 2006 | Roche |
| NCT00316758 | Phase 2 | Feb 1, 2006 | Roche |
| NCT00368368 | Phase 1 | Jan 1, 2006 | Roche |
| NCT00266240 | Phase 2 | Nov 1, 2005 | Roche |
| NCT00266253 | Phase 2 | Nov 1, 2005 | Roche |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 8 | 8 | 2 | 2005 |
1 organizations
Page 1 / 1